Best Addiction and Substance Abuse Grants in Rhode Island

The National Institute on Drug Abuse (NIDA) is launching a specialized entrepreneurship program aimed at life science researchers in the field of substance use disorders (SUD). This initiative will equip researchers with essential skills to transform their innovative ideas into viable products, focusing on aspects such as market evaluation, customer discovery, and intellectual property. The course will be delivered in a hybrid format to engage US-based SUD researchers effectively, fostering collaboration and advancing the field.

The NIH is offering access to biospecimens from the ABCD, HBCD, and PATH studies to promote research on health and disease across a lifetime. This initiative encourages projects that utilize these samples to deepen understanding of genetic and environmental influences, particularly substance exposure. Researchers can submit proposals to maximize the scientific utility of these resources, in alignment with the goals outlined under federal health regulations.

This NOFO invites applications for innovative research aimed at developing and implementing interventions to prevent and treat substance use disorders (SUDs) and overdose. It encourages studies that can rapidly advance candidate solutions towards regulatory approval or clinical use, while also addressing co-morbid SUDs. The initiative supports a wide range of research including basic, clinical, translational, and implementation strategies to tackle drug misuse and related health issues, such as HIV/AIDS.

Just One More Grant aims to transform lives by providing financial support to individuals and nonprofit organizations in the U.S. who are overcoming challenges like mental health issues, drug misuse, and educational barriers. The foundation encourages applications from those committed to personal growth and community support. Though current grants are paused for nonprofits, interested individuals with actionable plans are invited to apply. More information and past winners can be found on their website.

Research institutions and similar organizations studying tobacco, alcohol, or cannabis policies and health equity can seek up to US $2,500,000 for projects in the U.S., including Rhode Island. US Dept. of Health & Human Services: National Institutes of Health supports policy research with community engagement to reduce substance-related disparities and promote cancer prevention.

The Fogarty Emerging Global Leader Award supports early career research scientists from low- or middle-income countries (LMIC) by providing research funding and mentored career development for three to five years. This program encourages LMIC scientists in health-related fields to develop projects aligned with their country's health priorities, fostering independent research careers within their institutions. Applications are welcomed from junior faculty members, enhancing global health research and capacity in LMICs.

The Emerging Global Leader Award (K43) offers essential research support and protected time for early career scientists in low- and middle-income countries. This program, aligned with NIH's clinical trials policy, aims to cultivate independent research careers by providing mentorship and funding over three to five years. Eligible candidates must hold a junior faculty position at an accredited LMIC institution, fostering the growth of research capacity in their regions.

The HEAL Initiative aims to identify new druggable targets for pain within the understudied proteome. This funding opportunity invites applications for pilot projects that generate preliminary data and tools for exploring these targets. The initiative seeks to enhance research on understudied proteins related to pain management, providing essential funding for biochemical and biological work. This NOFO is part of the NIH's broader effort to develop novel medications that address various aspects of opioid addiction and its consequences.

The NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA) aims to renew support for two research consortia focusing on the biological mechanisms of excessive alcohol consumption and Alcohol Use Disorder (AUD). By utilizing advanced technologies and fostering collaboration across multiple sites, this initiative seeks to standardize neurofunctional measures and enhance reproducibility in findings. Investigators are encouraged to prepare for future applications to this NOFO, which will utilize the U24 activity code.

The Rapid Response Opioid and Pain Management ECHO Funding Opportunity by the Association of State and Territorial Health Officials (ASTHO) aims to enhance clinician training in effective pain management strategies. This initiative focuses on non-opioid treatments, substance use screening, and risk reduction counseling, promoting compassionate care while addressing public health challenges and ensuring continuity for patients affected by prescription disruptions. The program seeks to improve overall health outcomes and reduce risks associated with opioid use.

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) invites proposals for Specialized Alcohol Research Centers (P50) to enhance interdisciplinary research on alcohol misuse and Alcohol Use Disorder (AUD). These centers aim to foster collaboration among researchers, focusing on innovative topics related to alcohol's effects on health across the lifespan. The program supports the development of research methodologies and mentorship for young investigators, addressing the complex challenges posed by alcohol misuse in society.

The Intervention Research to Improve Native American Health (IRINAH), led by the National Institute on Drug Abuse, focuses on enhancing health outcomes in Native populations. It supports research to identify causes of health issues, develop and test effective interventions, and implement strategies that promote sustainability. Emphasizing community strengths, the initiative aims to rigorously evaluate solutions to reduce health disparities, ensuring interventions can be adapted and shared across diverse communities.

The Office of National Drug Control Policy is inviting applications to create a surveillance system that connects drug toxicology testing results and interviews from emergency department patients with the illicit drug supply in various U.S. communities. This project aims to enhance drug consumption surveillance, identify deficiencies in current drug testing methods, and promote collaboration among public health and safety organizations to effectively tackle the ongoing drug crisis.

The HEAL Initiative: Pain Research Enhancement Program (PREP) supports R15-eligible Principal Investigators in conducting innovative pain research. This program encourages interdisciplinary partnerships and aims to enhance the research environment for health professional trainees. Key application deadlines include November 19, 2024, and October 28, 2025, with specific dates for AIDS-related applications. By fostering collaboration, the initiative seeks to advance understanding and treatment of pain.

The Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed) aims to support investigator-initiated resources that enhance biomedical research on a national level. Through this non-hypothesis-driven grant, essential data, materials, and services will be provided to facilitate progress in the alcohol research community. The resources must be available to qualified investigators and should not replicate existing commercial offerings, ensuring high-quality and cost-efficient support for diverse research activities.

The Syringe Service Program Grant, offered by The Comer Family Foundation, aims to enhance harm reduction initiatives by funding syringe access programs across the U.S. These programs provide sterile syringes, education, and support services to mitigate the risks associated with drug use, including HIV and hepatitis transmission. Priority is given to organizations in underserved areas and those led by marginalized communities. Grants are available for operational costs, program development, and staff training, with a focus on sustainability and local partnerships.

The Levin Family Foundation Grant supports nonprofits focused on critical issues in Montgomery County, Ohio, such as the opiate epidemic, human trafficking, anti-bullying, and suicide prevention. Established in 1996, the foundation has invested over $12 million globally, emphasizing projects that align with its mission. Eligible organizations must be IRS 501(c)(3) tax-exempt. Priority is given to initiatives in the Greater Dayton Area, fostering positive community impact.

The National Institute on Drug Abuse (NIDA) aims to establish a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics. This Center will educate researchers on product development for SUD therapies and provide technical and financial support for initial experiments. It encourages collaboration and outreach to enhance research efforts in drug addiction. Investigators with relevant expertise are invited to consider applying for future opportunities to develop impactful solutions in SUD pharmacotherapeutics.

The Fy 2026 Drug Court Training and Technical Assistance Cooperative Agreement, led by ONDCP, aims to enhance access to evidence-based addiction treatments through drug courts. This initiative focuses on educating and training stakeholders to implement effective treatment strategies for individuals with addiction, particularly those facing co-occurring mental health conditions. By reducing criminal justice costs and recidivism rates, the program supports the President's priorities for long-term recovery and improved public health.

The Albert G. and Olive H. Schlink Foundation, established in 1966, has significantly impacted Ohio's nonprofit sector by increasing its annual grant distribution from an initial $500 to over $1.4 million in 2023. The Foundation prioritizes organizations with ties to Erie and Huron Counties and emphasizes thoughtful evaluation of all grant applications. With a focus on community needs, it continues to honor the founders' legacy while adapting to the evolving demands of local nonprofits.

The Tobacco Centers of Regulatory Science (TCORS) program, supported by the NIH and FDA, aims to foster research centers that enhance the scientific understanding of tobacco regulation. These centers will conduct hypothesis-driven projects on critical topics such as addiction, health effects, and marketing. By providing a multidisciplinary approach, TCORS seeks to inform public health strategies and ensure effective implementation of the Family Smoking Prevention and Tobacco Control Act.

The Bernau Family Foundation Grant aims to enhance individual lives and foster positive leadership through funding initiatives that provide long-term solutions. Grants are awarded to IRS-designated public charities or nonprofits, emphasizing projects that promote civic responsibility, education, and mentor programs. The foundation prioritizes smaller organizations that encourage meaningful community engagement and constructive change, ensuring a lasting impact on society.

The NCRG Large Grant, provided by the International Center for Responsible Gaming, supports high-quality research on gambling disorders and responsible gambling. Eligible applicants can request up to $75,000 annually for a maximum of 24 months, totaling $187,500. The grant emphasizes scientific rigor through its advisory board, ensuring only the best proposals receive funding. This initiative aims to advance understanding and treatment of gambling-related issues through peer-reviewed research.

The ICRG Seed Grant supports innovative research aimed at understanding and treating gambling disorders. With a focus on pilot studies, secondary data analysis, and developing new methodologies, it encourages both established and early-career researchers to apply for funding up to $40,000. The grant emphasizes the importance of addressing critical issues in gambling research while ensuring the inclusion of diverse participant groups. This initiative aims to enhance public education and promote responsible gaming practices.

FY25 Veterans Treatment Court Program

Executive Summary

This NOFO will support the implementation and enhancement of veterans treatment court (VTC) operations. VTCs connect veterans who come in contact with the justice system to treatment for substance use disorders (SUD), mental health disorders (MHD), co-occurring mental health and substance use disorders (MHSUD), post-traumatic stress disorder (PTSD), and traumatic brain injury (TBI). Funding supports service coordination, and recovery support services. VTCs integrate mandatory drug testing, incentives and sanctions, and transitional services in judicially supervised criminal court settings that have jurisdiction over veterans with behavioral health treatment needs. These courts aim to reduce recidivism and overdose fatalities, while increasing access to treatment and recovery support that leads to long-term recovery.

Category 1 supports the planning and implementation and/or launch of a VTC. These courts will support core capacity and provide critical behavioral health treatment, case management and coordinated judicial supervision, sanctions and incentives, and other supportive services, such as transitional housing, peer recovery services, relapse prevention and employment services, that can reduce recidivism.

Program Description

Planning and Implementation grants are available to eligible jurisdictions ready to commit to a 6- month planning phase followed by an implementation and/or launch of a VTC that supports core capacity and provides critical behavioral health treatment, case management and coordinated judicial supervision, sanctions and incentives, and other supportive services, such as transitional housing, peer recovery services, relapse prevention and employment services, that can reduce recidivism, including serving veterans who cannot or do not have access to Department of Veterans Affairs (VA) services